Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Avastin (bevacizumab) with mFOLFOX6 for treatment-naïve metastatic colorectal cancer (± KRAS mutations) has been withdrawn, with Cetuxi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• ERBITUX (cetuximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: WITHDRAWN